These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35535424)

  • 1. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
    Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
    Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
    Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
    Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
    Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk.
    Hughan SC; Hughes CE; McCarty OJ; Schweighoffer E; Soultanova I; Ware J; Tybulewicz VL; Watson SP
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):422-9. PubMed ID: 17110603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
    Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
    J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
    Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW
    J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.
    Hughes CE; Finney BA; Koentgen F; Lowe KL; Watson SP
    Blood; 2015 Jan; 125(1):144-54. PubMed ID: 25352128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
    Yokomori R; Shirai T; Tsukiji N; Oishi S; Sasaki T; Takano K; Suzuki-Inoue K
    Platelets; 2023 Dec; 34(1):2281941. PubMed ID: 38010137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.
    Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP
    Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane.
    Arthur JF; Shen Y; Kahn ML; Berndt MC; Andrews RK; Gardiner EE
    J Biol Chem; 2007 Oct; 282(42):30434-41. PubMed ID: 17690106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
    Suzuki-Inoue K; Inoue O; Frampton J; Watson SP
    Blood; 2003 Aug; 102(4):1367-73. PubMed ID: 12730118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
    Moroi AJ; Watson SP
    J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
    Zheng TJ; Parra-Izquierdo I; Reitsma SE; Heinrich MC; Larson MK; Shatzel JJ; Aslan JE; McCarty OJT
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1231-C1250. PubMed ID: 35938677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.
    Zhang P; Solari FA; Heemskerk JWM; Kuijpers MJE; Sickmann A; Walter U; Jurk K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
    Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
    J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
    Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
    Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets.
    Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP
    J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.